Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity

Otologic immunoglobulin G4–related disease (IgG4-RD) is a rare and a relatively newer pathology. COVID-19, IgG4-RD, and type 2 diabetes, all have independent capabilities to considerably affect the immune system. The immunological effects of COVID are a global conundrum; consequently, the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Ashish, Patnaik, Uma, Singh, Kamalpreet, Jayadevan, Jijesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721396/
https://www.ncbi.nlm.nih.gov/pubmed/36504510
http://dx.doi.org/10.1016/j.mjafi.2022.10.009
_version_ 1784843765350924288
author Jain, Ashish
Patnaik, Uma
Singh, Kamalpreet
Jayadevan, Jijesh
author_facet Jain, Ashish
Patnaik, Uma
Singh, Kamalpreet
Jayadevan, Jijesh
author_sort Jain, Ashish
collection PubMed
description Otologic immunoglobulin G4–related disease (IgG4-RD) is a rare and a relatively newer pathology. COVID-19, IgG4-RD, and type 2 diabetes, all have independent capabilities to considerably affect the immune system. The immunological effects of COVID are a global conundrum; consequently, the association of this trio (otologic IgG4-RD, COVID-19, and type 2 diabetes), the only reported case in literature, paves the way for a fascinating interplay to explore the knowledge of which would help optimize treatment and improve disease outcomes.
format Online
Article
Text
id pubmed-9721396
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97213962022-12-06 Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity Jain, Ashish Patnaik, Uma Singh, Kamalpreet Jayadevan, Jijesh Med J Armed Forces India Case Report Otologic immunoglobulin G4–related disease (IgG4-RD) is a rare and a relatively newer pathology. COVID-19, IgG4-RD, and type 2 diabetes, all have independent capabilities to considerably affect the immune system. The immunological effects of COVID are a global conundrum; consequently, the association of this trio (otologic IgG4-RD, COVID-19, and type 2 diabetes), the only reported case in literature, paves the way for a fascinating interplay to explore the knowledge of which would help optimize treatment and improve disease outcomes. Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd. 2022-12-05 /pmc/articles/PMC9721396/ /pubmed/36504510 http://dx.doi.org/10.1016/j.mjafi.2022.10.009 Text en © 2022 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Jain, Ashish
Patnaik, Uma
Singh, Kamalpreet
Jayadevan, Jijesh
Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
title Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
title_full Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
title_fullStr Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
title_full_unstemmed Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
title_short Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
title_sort enigma of otologic immunoglobulin g4–related disease, covid-19, and uncontrolled diabetes: the unholy trinity
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721396/
https://www.ncbi.nlm.nih.gov/pubmed/36504510
http://dx.doi.org/10.1016/j.mjafi.2022.10.009
work_keys_str_mv AT jainashish enigmaofotologicimmunoglobuling4relateddiseasecovid19anduncontrolleddiabetestheunholytrinity
AT patnaikuma enigmaofotologicimmunoglobuling4relateddiseasecovid19anduncontrolleddiabetestheunholytrinity
AT singhkamalpreet enigmaofotologicimmunoglobuling4relateddiseasecovid19anduncontrolleddiabetestheunholytrinity
AT jayadevanjijesh enigmaofotologicimmunoglobuling4relateddiseasecovid19anduncontrolleddiabetestheunholytrinity

Ejemplares similares